* This is the Professional Version. *
Urinary Tract Infection in Pregnancy
(See also Urinary Tract Infections (UTI).)
UTI is common during pregnancy, apparently because of urinary stasis, which results from hormonal ureteral dilation, hormonal ureteral hypoperistalsis, and pressure of the expanding uterus against the ureters. Asymptomatic bacteriuria occurs in about 15% of pregnancies and sometimes progresses to symptomatic cystitis or pyelonephritis. Frank UTI is not always preceded by asymptomatic bacteriuria. Asymptomatic bacteriuria, UTI, and pyelonephritis increase risk of preterm labor and premature rupture of the membranes.
Treatment of symptomatic UTI is not changed by pregnancy, except drugs that may harm the fetus are avoided (see Table: Some Drugs With Adverse Effects During Pregnancy). Because asymptomatic bacteriuria may lead to pyelonephritis, it should be treated with antibiotics similar to an acute UTI.
Antibacterial drug selection is based on individual and local susceptibility and resistance patterns, but good initial empiric choices include the following:
After treatment, proof-of-cure cultures are required.
Women who have pyelonephritis or have had more than one UTI may require suppressive therapy, usually with trimethoprim/sulfamethoxazole (before 34 wk) or nitrofurantoin, for the rest of the pregnancy.
In women who have bacteriuria with or without UTI or pyelonephritis, urine should be cultured monthly.
Asymptomatic bacteriuria, UTI, and pyelonephritis increase risk of preterm labor and premature rupture of the membranes.
Initially treat with cephalexin, nitrofurantoin, or trimethoprim/sulfamethoxazole.
Obtain proof-of-cure cultures after treatment.
For women who have had pyelonephritis or more than one UTI, consider suppressive therapy, usually with trimethoprim/sulfamethoxazole (before 34 wk) or nitrofurantoin.
Drug NameSelect Brand Names
trimethoprimNo US brand name
nitrofurantoinFURADANTIN, MACROBID, MACRODANTIN
* This is a professional Version *